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ABSTRACT 
Surgical robotics and supporting technologies have really become a prime example of modern applied 
information technology infiltrating our everyday lives. The development of these systems spans across 
four decades, and only the last few years brought the market value and saw the rising customer base 
imagined already by the early developers. This chapter guides through the historical development of the 
most important systems, and provide references and lessons learnt for current engineers facing similar 
challenges. A special emphasis is put on system validation, assessment and clearance, as the most 
commonly cited barrier hindering the wider deployment of a system.    
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INTRODUCTION 
Traditionally, robotics is a combination of mechatronics, electronics and software. The recent 
development in robot structures and components gradually enabled the rise of smaller scale and fine 
mechatronic structures that can be used in various applications beyond the industry (Habib, 2006). These 
trends can also be tracked in standardization activities, the newly released ISO 13482:2014 is the first 
representative of a new family of standards aimed at service robotics. It applies to personal care robots 
designed to the quality of life of humans, excluding medical applications. Service robots are to support 
their users and humanity in various tasks, from elderly care to demining (Habib, 2007).   
A rapidly growing field within service robotics is medical robotics, including rehabilitation robotics and 
surgical systems. In the past decades, numerous different robotic surgery devices have been created, and 
only a few reached the market. The Medical Robotic Database (Pott, 2014) lists over 450 international 
surgical robotic projects, of which several dozen are with the potential to become commercially available. 
Parallel, the number of surgical robotics related publications has been steadily rising in the past years 
(O’Toole et al., 2010), making Computer-Integrated Surgery (CIS) one of the leading areas within 
medical technology. 
CIS refers to the entire field of technology-aided interventional medicine, from image processing and 
augmented reality applications to automated tissue ablation. CIS means the combination of innovative 
algorithms, robotic devices, imaging systems, sensors and human–machine interfaces. These systems 
should work cooperatively with physicians in the planning, execution and evaluation phases of surgical 
procedures (Taylor & Kazanzides, 2008). A subfield of CIS is called Image-Guided Surgery (IGS), where 
the digital system is not necessarily involved in the physical part of the operation, but improves the 
quality of surgery by better visualization or guidance. IGS means the accurate registration (correlation 
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and mapping) of the operative field to a pre-operative (typically Magnetic Resonance Imaging—MRI, or 
Computer Tomography—CT) imaging or intra-operative (ultrasound—US, fluoroscopy) data set of the 
patient, providing free-hand navigation, positioning accuracy of equipment, or guidance for a mechatronic 
system. IGS systems have been successfully prototyped and commercialized, and now being used in 
neurosurgery, radiotherapy, pediatrics, orthopedics and various other fields. 
This chapter introduces the aims and means of surgical robot development, giving a better understanding 
of the difficulties the field is challenged with through examples taken from existing robots. Medical 
robots are mostly employed for the accuracy and reliability of their mechanics; however, it may still be 
hard to fully exploit their features, as surgical tasks are typically unique, involving the semi-autonomous 
manipulation of deformable objects in an organic, limited environment.  
Medical imaging gives the capability to navigate and position a surgical tool at the target point. 
Furthermore, there is the option to introduce advanced digital signal processing to control or record the 
spatial point-of-interests and motions (Kazanzides et al., 2010). This can be useful for surgical simulation 
and risk-free training. Finally, robotized equipment can greatly add to the ergonomics of the procedures. 
The main advantages of robotic surgery systems—based on (Karas & Chiocca, 2007) and (Lirici et al., 
1997)— are the following: 
• superior 3D spatial accuracy provided by the robot, 
• specific design for maximum performance (including miniature robots), 
• stabilization of the instruments within the surgical field, 
• advanced ergonomics supporting long procedures, 
• stable performance, 
• high fidelity information integration, 
• invulnerability to environmental hazards, 
• patient advantages (reduced blood loss, less trauma, shorter recovery time), 
• decreased costs (per treatment) due to shorter hospitalization and recovery, 
• possibility to provide better and more realistic training to physicians. 
Further optional benefits:  
• improvement of manual dexterity, motion scaling, 
• physiological tremor filtering, 
• integrated 3D vision system with high definition (HD) resolution. 
Robots have been introduced to the operating room primarily to provide higher accuracy and dexterity. 
They can support surgeons with advanced targeting, steady positioning and task execution with a 
precision beyond human capabilities. Therefore, the treatment delivery accuracy and objective evaluation 
of interventional systems is crucial, especially when they are image-guided and operating semi-
autonomously (Stiehl et al., 2007). Errors and imperfections may originate in: 
• CT imaging errors, 
• volume model generation errors, 
• treatment planning errors, 
• errors introduced by hardware fixturing, 
• intra-operative data noise, 
• registration errors, 
• inherent inaccuracies of surgical tools and actions.  
It is important to keep in mind from the first stage of development which errors will be critical regarding 
the final application of the system, and how to minimize their disturbing effect.  
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SYSTEM DEVELOPMENT STRATEGIES
 
 
CIS systems are strongly application-oriented (ideally driven by a strong clinical need), therefore their 
entire architecture may be defined by the targeted treatment. It may be extremely hard to switch from one 
concept to another during a latter development, therefore strategic planning is a must. Different categories 
of surgical robots have been built for various procedures. Hand-held and directly controlled devices may 
serve as an incremental upgrade for existing tools, while teleoperated systems represent a whole different 
field. The advantage of versatility comes with the emergence of issues with control, latency handling and 
emergency protocols.  
Robots can be involved in medical procedures with various level of autonomy (Nathoo et al., 2005), and 
each type requires different approach during system development. Some of them serve as a robust tool 
holding equipment having been directed to the desired position. Systems that are able to perform fully 
automated procedures—such as CT-based biopsy or cutting—are called autonomous or supervisory 
controlled devices. On the other hand, if the robot is entirely teleoperated or remote-controlled (robotic 
telesurgery system) the surgeon is absolutely in charge of its motion. The latter consists of three parts:  
 one or more slave manipulators,  
 a master controller  
 a vision system providing visual feedback to the user.  
Based on the gathered visual (and sometimes haptic) information, the surgeon guides the arm by moving 
the controller and closely watching its effect. In most of the cases, the slave system and camera are acting 
as the remote hands and eyes of the surgeon, and therefore they are key elements of the operation.  
Modifying the teleoperation control paradigm we can introduce cooperative control (also called shared 
control or hands-on surgery). It means that the surgeon is directly giving the control signals to the 
machine through e.g., a force sensor. It is possible to read and process these signals in real-time to create 
the robot’s motion. The human is always in contact with the robot, as the master and the slave devices are 
physically identical. In this case, the robot is the extension of the doctor’s hand, equipped with special 
features and effectors. This approach keeps the human in the loop, and still allows the surgeons to use all 
their senses. It is often used in the case of micro-manipulation operations, such as micro-vascular, 
urologic, eye or brain procedures. Cooperative control is a promising way to provide highly integrated 
robotic support for procedures while applying all the necessary safety standards. 
It is commonly quoted that a medical product needs 10–15 years to grow from the conception of an idea 
to commercialization. This extremely long time-to-market period requires wise considerations from the 
developers to ensure the continuous funding of the project. Developing an engineering prototype is only 
the first step, success in business requires various skills and sometimes entirely different approach 
towards R&D. The history of the first generation of surgical robots summarized in the next session 
provides great examples and lessons on the critical aspects of the development process.  
 
FIRST PROTOTYPES 
 
 
Early concepts of surgical telerobots 
Since the 1980s, hundreds of medical robotic research projects have been initiated, creating a set of 
instruments for remote and local robotic surgery. CIS and telemedicine have become widely used around 
the world, surgeons and engineers created systems and networks for advanced patient care, demonstrated 
over a hundred different procedures, transcontinental surgery and even performed procedures in 
weightlessness (Doarn et al., 1998). 
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The general idea of telerobotic health care in space was born in the early ’70s, proposed in a study for the 
National Aeronautics and Space Administration (NASA) to provide surgical care for astronauts with 
remote controlled robots (Alexander, 1972). The concept-system, presented in Fig. 1. shows very well the 
fundamental characteristics of a complete teleoperational system, although the first prototypes were only 
built almost 15 years later. In the late ’80s, the idea of commercial surgical robotics was born to extend 
the surgeons’ dexterity, multiple academic centers started to develop new prototypes. 
 
Figure 1. The very first design concept of a surgical robot system, aimed to support astronauts in space 
  (Alexander, 1973). 
It was first proven thirty years ago that robotics can extend human surgeons’ capabilities. The first robot 
used on a human patient was a Puma 200 (Programmable Universal Machine for Assembly), 
manipulating a biopsy cannulae using a Brown–Roberts–Wells stereotactic frame (mounted on the robot’s 
base). The operation took place in the Memorial Medical Center (Long Beach, CA) in 1985 (Kwoh et al., 
1988). In later experiments, the Puma performed complete stereotactic neurosurgical operations based on 
CT scans, processing the scanned images, positioning the arm and manipulating different probes (Fig. 2).  
 
  
Figure 2.  The first robot that performed (assisted with) human surgery in 1985 (Kwoh, 1988). Dr. 
Kwoh with the Unimate robot prepared for stereotactic neurosurgery. (Image credit: Corbis)  
 
The U.S. Army has long been interested in robotic surgery for the battlefield, and currently, the 
Telemedicine & Advanced Technology Research Center (TATRC) supports the development of 
prototypes to test and extend the reach of remote health care. Physicians were first able to affect distant 
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patients with the Green telepresence system in 1991 (Bowersox et al., 1996), and the first long distance 
telerobotic experiment was in 1993 between NASA Jet Propulsion Laboratory (JPL) in Pasadena and 
Milan (Rovetta et al., 1996). The U.S. Department of Defense (DoD) aims to develop a system—Trauma 
Pod—by 2025 that allows combat surgeons to perform lifesaving operations from a safe distance (Satava, 
1995) and (Garcia et al., 2009). Much of these projects created the basis of the most successful surgical 
robot, the da Vinci.  
The da Vinci Surgical System 
The market leader da Vinci robot from Intuitive Surgical Inc. (Sunnyvale, CA), is a complete teleoperated 
system created with roughly $500M investment. The company was founded in 1995, licensing many 
promising technologies, and by 1997 the first functional surgical robot (Lenny) was ready for animal 
trials. Concepts from around the world and various engineering prototypes were integrated into the 
project (DiMaio et al., 2011):  
• the Black Falcon teleoperated surgical robot from MIT (Madhani et al., 1998), 
• the Robot Assisted Microsurgery (RAMS) workstation from NASA JPL, 
• PROBOT prostate surgery device from Imperial College, 
• teleoperation control techniques from University of Washington (UW),  
• Green telepresence surgery system developed at Stanford Research International (SRI). 
 
 
Figure 3.  The evolution of the da Vinci robot’s slave manipulators.  a–c)The original Black 
falcon prototype, developed at MIT. (Courtesy of Science Photo Library.)  d–f) The slave 
mechanisms of Leny, Mona and first da Vinci, respectively. (Courtesy of Intuitive Surgical Inc.)  
 g) The da Vinci Si version of the slave arms. (Courtesy of Intuitive Surgical Inc.)  h) The newest 
da Vinci Xi’s Patient Side Manipulators. (Courtesy of Intuitive Surgical Inc.) 
 
The next prototype―Mona—performed the first human trials in Belgium in 1997, and the first da Vinci 
unit was created within a year (Guthart & Salisbury, 2000). The U.S. Food and Drug Administration 
(FDA) cleared the system for general laparoscopic surgery (August 2000), thorascopic surgery (March 
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2001) and laparoscopic radical prostatectomy (May 2001), followed by many other approvals. Most 
recently, it was approved for transoral otolaryngologic procedures and adjunctive mediastinotomy to 
perform coronary anastomosis during cardiac revascularization. 
The original da Vinci system is basically a smart tool and interface between the hands of the surgeon and 
the laparoscopic instruments in use. The patient side consists of two/three tendon-driven, 6+1 Degrees of 
Freedom (DOF) slave manipulators (Fig. 3). These are designed with a Remote Center of Motion (RCM) 
kinematics, resulting in an inherent safety regarding the spatial stability of the entry port. This means that 
the gross positioning (passive) arms can move the base point of the actuated arms, and therefore define 
the RCM as the fixed entry point through their semi-parallel kinematics. The camera holder arm navigates 
in 3 DOF, controlled with the same master console. The system provides high quality 3D vision with 
stereo-endoscopes, adjustable tremor filtering (6 Hz) and motion scaling (1:1–1:5). The total weight of the 
system is 850 kg, and the setup takes up significant floor space in the Operating Room (OR). The intrinsic 
accuracy of the robot was measured to be 1.35 mm (Target Registration Error—TRE (see next section) 
with the points not used in registration), with 1.02 ± 0.58 mm (mean ± standard deviation—STD) Fiducial 
Localization Error (FLE) (Kwartowitz et al., 2006). The newer version had similar FLE, 1.05 ± 0.24 mm 
(Kwartowitz et al., 2007). To compensate for any application errors (and to avoid safety hazards), the 
robot only follows the movements of the surgeon. The arm configuration of the latest da Vinci Xi has 
been changed to improve dexterity and the range of motion. 
Manipulation precision comes at a price, the da Vinci S version consisted of 10,000 individual parts, and 
the operating code stretches beyond 1.4 million lines. There are 39 backdriveable Maxon motors (maxon 
motor ag, Sachseln, CH) in each robot, most of them equipped with magnetic encoders. Communications 
in the da Vinci is acquired via Transmission Control Protocol over Internet Protocol (TCP/IP) using NI 
USB-6009 data acquisition boards (National Instrument, Austin, TX). The controller computer deals with 
the 48 DOF at an update rate of 1.5 kHz. There are 48 encoders and 96 analog input channels supported 
by parallel floating point DSP architecture with a peak computational power of 384 Mflops and a 
sustained processing power of between 128–256 Mflops. The robot has a network of 24 micro-controllers 
and integer DSPs performing data transfer and health watchdog functions. Velocity control algorithms are 
employed mostly with 2–3 filters, the one in the forward link is used to attenuate master input commands 
that could cause instrument tip vibrations otherwise. Redundant sensors, hardware watchdogs and real-
time error detection protocols ensure fail-safe operation of the robot. The da Vinci uses an Insite Vision 
and Navigator Camera Control with two 3-chip cameras and two separate optical channels generating 
two images delivered separately to each eye of the surgeon. It gives 1000 frames of the instrument 
position per second and filters each image through a video processor that eliminates background noise 
(Haidegger, 2010).  
Intuitive continued perfecting the system, and the second generation—da Vinci S—was released in 2005. 
The setup and docking procedures were streamlined, the 4
th
 arm became more versatile, the slave arms 
were redesigned and arranged in a way to avoid collision and the console was enhanced with streaming 
images. The next version—da Vinci Si—became available in 2009 with improved full HD camera 
system, advanced ergonomic features and most importantly, the possibility to use two consoles for 
assisted surgery (Fig. 4). The da Vinci Xi was introduced in April 2014 featuring a brand new slave-side 
arm structure. The da Vinci Xi's features include a new overhead arm architecture designed to facilitate 
anatomical access from multiple directions, a new endoscope architecture that can fit to any of the slave 
arms, smaller, thinner arms with newly designed joints, offering greater range of motion. The slave cart 
positioning has been streamlined as well, and enabled with a laser-targeting system.  
More recently, Intuitive received FDA clearance for its new da Vinci Sp single port robot system that we 
have already seen 5 years ago as a prototype. The system is designed for urologic minimally-invasive 
procedures that are already performed via a single incision, however it may only be commercially 
available from the end of 2015. According to the company, the Sp patient-side cart is designed to expand 
single-incision product range. It integrates an articulated 3D HD camera, along with three agile 
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instruments—which have two more degrees of freedom than the single-site instruments. All these are 
fitted through a 25 mm diameter cannula. 
Having realized the potential in robotic surgery training, Intuitive has released its portable da Vinci Skills 
Simulator, which can be attached to a da Vinci Si and Xi systems. It allows users to practice unassisted or 
with supervision through a set of exercises ranging from camera handling to electric coagulation. The 
open architecture of the software allows for the future incorporation of additional modules. The simulator 
is continuously upgraded by the independent company called MIMIC 
(http://mimicsimulation.wordpress.com/). 
In recent years, Intuitive has been focusing on enlarging the tool inventory, developing useful and specific 
end effectors for various procedures (e.g., US probe, FireFly—fluoroscopic imaging, etc.). Also, they put 
an effort to provide a generic research interface to help institutes developing compatible tools and 
techniques. In a joint venture with the CISST ERC they are about to release the SAW architecture 
(Surgical Assistant Workstation) that would further integrate the robot into any surgical information 
system. Current extensions allow visual overlay and augmented reality features in a prototype version 
(Kazanzides et al., 2010). 
As of today, there are around 3100 da Vincis around the world, 3/4 of them in the U.S. The number of 
successful procedures performed is close to a million; the most successful applications being 
prostatectomy and hysterectomy. According to Intuitive, over 80% of all radical prostate removal 
procedures were performed robotically in the U.S. in 2013. One of the key elements in the success of the 
system is the universality of the platform. Despite the fact that originally it was planned to be used for 
beating heart surgery, it was versatile enough to shift the focus to urologic and gynecological procedures 
that became the most lucrative business for the company. Their extensive patenting strategy allowed them 
a freedom to operate in the market over the past 20 years.  
 
Figure 4.  The da Vinci Xi system, debuted in 2014. (Courtesy of Intuitive Surgical Inc.)  
 
The NeuroMate neurosurgical robot 
Although the NeuroMate was the first robot to gain CE mark (Conformité Européenne—European 
Conformity) in Europe and then the FDA approval in 1997 for stereotactic neurosurgical procedures, it 
could not achieve any similar success to the da Vinci. Originally designed based on an industrial robot at 
the Grenoble University and developed market-ready by Innovative Medical Machines International 
(IMMI—Lyon, France), the 5 DOF NeuroMate provides accurate and trusted assistance for supervised 
needle positioning for brain biopsy (Fig. 5). Combined with pre-operative images, it offers real-time 
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visualization to give the surgeon precise location of a tumor. It has an approval for neuro-endoscopic 
applications and for frameless stereotactic surgery (Li et al., 2002).  
The robot consists of 5 revolute joints, each mobilized by a separate, high precision servo. The joint 
values are read by encoders with a resolution of 1/26825 degree due to the high gearing. The Neuromate 
contains embedded joint controller boards that are integrated into the links of the robot, significantly 
reducing the required cabling. Each joint controller board contains a microprocessor and is responsible for 
controlling up to two axes of the robot, including the power amplification. The power supplies are placed 
in the triangle shaped base, eliminating the need for a separate controller rack. The ISS version of the 
system communicates with the main PC through a Controller Area Network (CAN) bus with a 18.2 ms 
communication cycle. On the lowest level, the joints are given position commands. The highest linear 
velocity of the robot is approximately 50 mm /sec. 
The NeuroMate’s reported intrinsic accuracy (i.e., the precision of the individual hardware and software 
components) is 0.75 mm, with a repeatability of 0.15 mm (Varma & Eldridge, 2006). In a human 
stereotactic surgical experiment conducted in 2002, the application accuracy (the overall precision in 
performing the desired task, as discussed below) was measured to be 0.86 ± 0.32 mm in frame-based 
configuration and 1.95 ± 0.44 mm in frameless model (Li et al., 2002). The average application accuracy 
of 10 different robots was measured to be 0.6 mm. In a more recent experiment, the intrinsic accuracy of 
the robot was 0.36 mm FRE and 0.36 ± 0.17 mm TRE (Haidegger et al., 2008). 
The technology was bought by Integrated Surgical Systems Inc. (ISS—Sacramento, CA) in 1997. In the 
first couple of years of operation, the company installed around 20 NeuroMate systems in the United 
States, Europe and Japan. However, due to the lack of sustainable market and investment for further 
innovation, the company ceased operations in the early 2000s. The NeuroMate technology was acquired 
first by Siemens Finance and Leasing (Munich, Germany), then by Schaerer Mayfield NeuroMate AG 
(Lyon, France) in 2007, and reappeared on the market in Renishaw plc’s (Wotton-under-Edge, UK) 
product line. It received a facelift, and runnning under the trademark neuro|mate (Fig. 5). More recently, 
the robot has been used for thousands of electrode implantation procedures for Deep Brain Stimulation 
(DBS), Stereotactic Electroencephalography (SEEG) and Transcranial Magnetic Stimulation (TMS). 
This also supports the importance of the ability to deploy a robotic system in various clinical fields.  
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Figure 5.  a) IGOR, the original industrial robot-based prototype for neurosurgery (Benabid et 
al., 1987).   b) IMMI’s NeuroMate (Li et al., 2002).   c–d) Current and next version of 
the system with newly designed interior controllers. (Courtesy of Renishaw plc.) 
 
ROBODOC for orthopaedics 
ROBODOC Surgical Assistant System shares a similar story to NeuroMate, it was the first robot of ISS, 
when the company was founded in 1990. Development began in 1986 at IBM T. J. Watson Center and 
U.C. Davis, aiming to create a bone milling robot (Pransky, 1997) and (Bargar, 2007). A 5 DOF IBM 
SCARA robot was custom designed for Total Hip Arthroplasty (THA—surgical shaping or alteration of 
the joint). The 3D planning station (called Orthodoc) together with the ROBODOC use pre-surgical 
images and software to first design the surgical procedure (Fig. 6). Surgeon can precisely define the 
desired cavity in the bone, size and position the prosthesis before the real surgery. In fact, the robot was 
originally aimed at canine surgery, and later changed the focus to human operations. The first-ever 
robotic human trial was performed in 1992 (Kazanzides, 2009), and later extended to being Total Knee 
Artroplasty (TKA) procedures as well. The company invested over $80M into system development.   
ROBODOC drills the bone without direct human control of the tool during the procedure; therefore the 
application accuracy of the system is critical. The robot has a 0.5 mm intrinsic accuracy, while the 
application accuracy was 1.2 mm in average, ranging from 1.0 to 3.5 mm in cadaver trials (Paul et al., 
1994). The later version of the device had around 0.1 mm dimensional error and 1.0 mm placement error, 
providing over 95% implant-bone contact (Taylor, 2001). Since 1994, ISS has sold around 80 systems 
across Europe and Asia, and in 2008, it became the first FDA approved automated bone milling robot, 
under Curexo Technology Corporation.  
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Figure 6.  a) The first engineering prototype of orthopedic robot at IBM T.J. Watson Center, 
created for canine hip surgery.  b–c) Early prototype of the ROBODOC system.  d) The ROBODOC, as 
sold by ISS until the early 2000s. (Courtesy of ISS Inc.)  e) The ROBODOC in its current form. 
 f) Concept figure of the next generation prototype. (Courtesy of Curexo Tech. Co.)  
 
CyberKnife radiosurgery system 
One of the most successful robotic applications is the CyberKnife from Accuray Inc. (Sunnyvale, CA). 
This stereotactic radiosurgery system integrates IGS with robotic positioning. The 6 MeV Linear 
Accelerator (LINAC) relatively light-weight photon device is mounted on a KUKA KR 240, 6 DOF 
industrial manipulator (Fig. 7). The idea was to combine existing hardware components to create an 
innovative device. This approach allows for faster prototyping, and shorter system development cycle. 
More than 200 units have been sold worldwide. The same concept has been used by SIEMENS lately 
with their Artis Zeego system for actuated X-ray imaging (SIEMENS, 2014). 
CyberKnife’s primary deployment is the irradiation of brain and spine tumors. X-ray cameras are used to 
track the spatial displacement of the patient and compensate for motion caused by e.g., breathing. The 
overall accuracy of the system is 0.42 ± 0.4 mm, while patient skin motions are detected with a 0.35 mm 
precision (Dieterich et al., 2003). The CyberKnife moves the radiation beam by physically repositioning 
the radiation source. It uses intra-corpuscular markers and Polaris (NDI Inc., Waterloo, ON) infrared 
cameras to track the patients’ moving body surface. To improve the accuracy, radioopaque fiducial 
markers can be implanted in/near the tumor region, several days before CT scanning for treatment 
planning. The fiducials—which are detectable in X-ray images—are used as reference markers to locate 
and track tumor location during patient alignment and treatment delivery. The Synchrony Respiratory 
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Tracking System builds a correlation model between the positions of periodically detected fiducials and 
the real-time locations of optically tracked markers placed on the chest to track tumor location. It uses 4D 
CT (imaging through time) to measure respiratory tissue motion and deformation and to account for the 
effect of displacement and deformation through the irradiation (Urshel, 2007).  
 
Figure 7.  a–b) First prototypes mounted on a Fanuc robot.  c–d) The first and second 
commercially available versions of the CyberKnife radiosurgery system mounted on a KUKA robot. 
(Courtesy of Accuray Inc.) 
Cleared by the FDA to treat tumors anywhere in the body since 2001, more than 70,000 patients had been 
treated and more than 180 systems were installed worldwide by 2009, and by 2012, over 100K procedures 
had been performed with over 244 systems sold. Despite the fact that it is significantly more expensive 
than the da Vinci (~€3M, and €10.000/ treatment), it has not set Accuray Inc. to such a speed profit curve 
simply because the consumables for a procedure do not scale that nicely. The company introduced the M6 
version, with multiple treatment planning, fiducial tracking, fixed collimators, variable aperture 
collimator and so (Fig. 8). 
 
Figure 8.  a–c) First versions of the new CyberKnife M6 series.  d) Designs of the consumer 
product. (Courtesy of Accuray Inc.) 
 
The iSYS systems 
A robotic system for CT and ultrasound-guided biopsies was initiated at the robotics laboratory of ARC 
Seibersdorf Research (Austria). The system used to be called B-Rob, and it was a 7 DOF robot integrated 
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on a mobile rack. A 4 DOF positioning stage was employed to direct the needle to the desired skin entry 
point. The complete system was thoroughly tested on needle-penetrable phantoms, where its application 
accuracy was 1.48 ± 0.62 mm, which was shown to be better than the traditional free-hand technique 
(Cleary et al., 2006). They broke with the concept of using large, universal manipulators to navigate tools, 
rather employed specialized hardware to suit the clinical needs of percutaneous procedures. This small-
scale system better integrates with the OR (Fig. 9a–b).  
The development of the second prototype (Fig. 9c–d) was motivated by the aim to provide a modular 
setup for a variety of clinical applications, to allow easy integration with other systems, while reducing 
technical complexity and costs. The robot is equipped with a Needle Positioning Unit (NPU) for fine 
orientation. The first gel phantom tests of the B-Rob II showed 0.66 ± 0.27 mm application accuracy in 
IG positioning. In-vitro trials with ultrasound guided biopsy specimen harvests followed, where the mean 
deviation of the needle tip from the center of the target was 1.1 ± 0.8 mm. The technology was licensed 
by iSYS Medizintechnik GmbH, and the robot got redesigned, to better fit the market (Fig. 9e–g). It has 
recently gained ISO certification and CE marking, and FDA approval in early 2014.  
 
Figure 9.  a–b) The B-ROB I. c–d) the B-ROB II prototypes (Cleary et al., 2006). e–f) The new 
design, created by iSYS and now commercially available (iSYS, 2014). 
 
SYSTEM CAPABILITY ASSESSMENT 
A major step in the evaluation of a system is performance assessment, especially in terms of spatial 
accuracy and safety. Thorough tests are required, as the overall precision may be the highly non-linear 
function of the intrinsic- and registration accuracies. After 20 years of development, there is still a strong 
need for objective measures in medical robotics. In this section, different test methods are presented to 
define system characteristics, working towards their validation.  
Accuracy numbers are used to convince the medical community about the improved patient outcome that 
robots can provide, therefore it is essential to have clear and well-founded metrics. 
In CIS, registration and accuracy metrics have been commonly borrowed from industrial robotics 
(precision, repeatability, etc.) and image analysis (FRE, TRE, etc.), but it is important to understand the 
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validity and limitations of these concepts. Similarly, the differences between intrinsic (technical) 
accuracy, registration accuracy and application accuracy are to be well observed. Examples of accuracy 
measurement techniques are presented here, illustrating the importance of correct, consistent reporting, 
facilitating the comparison of different devices. 
Precision of robotic systems can be represented by the accuracy and repeatability of the device to 
characterize the overall effect of the encoders’ fineness, rigidity of the structure and the compliance of the 
hardware elements (the servo motors, the gears or the links). Both terms are defined for industrial robots 
in the International Organization for Standardization (ISO) 9283 standard (ISO TC-184/SC2 Robots and 
Robotic Devices). Accuracy refers to a robot’s ability to position its end at a desired target point within 
the working volume. Generally, the absolute positioning accuracy shows the error of the robot when 
moved to a prescribed joint angle or Cartesian position. This expresses the mean difference between the 
actual pose (position and orientation) and the pose calculated from the mathematical model of the robot. 
“Repeatability is the ability of the robot to reposition itself to a position to which it was previously 
commanded or trained”, as defined in (Nof, 1999). It is the standard deviation of the positioning error 
acquired through multiple trials to reach the same joint values (Fig. 10). Repeatability is typically smaller 
for manipulators than accuracy, while both numbers are largely dependent on speed, payload and the 
range of motion (Stiehl et al., 2007). From the clinical point of view, the accuracy of treatment delivery is 
important, to know the task specific uncertainty. However, this may be difficult to measure routinely; it 
requires mock operations, cadavers or the use of pre- and post-operative imaging combined. Some 
manufacturers have tried to construct advanced measurement tools to facilitate system assessment. 
Alternatively, phantoms (artifacts) can also be used to replicate clinical conditions as much as possible. 
 
Figure 10.  Difference between accuracy and repeatability. Based on (Stiehl et al., 2007).  
 
There are three different types of accuracies (in terms of spatial errors) that can be specified with different 
error numbers (determined in general) according to (Grunert et al., 2003) and (Kronreif, 2011): 
• intrinsic (technical) accuracy (0.1–0.6 mm), 
• registration accuracy (0.2–3 mm), 
• application accuracy (0.6–10 mm). 
Intrinsic accuracy applies to certain elements, such as the robot or the navigation system. It describes the 
average error of the given component in operational use. Random errors (e.g., mechanical compliance, 
friction, loose hardware), resolution of the imaging device, inadequate control and noise can all result in 
low intrinsic accuracy. On the user interface side, discretized input and modeling errors may further 
decrease precision.  
Registration errors are also present, as computational methods involve some kind of residual errors. It is 
only possible to find a normalized (e.g., least squares optimized) solution for a mathematical fitting 
problem. In IGS, a major source of error can originate in the localization of the markers (different types, 
forms and materials), displacement of the fiducials and determination of the center of the fiducials. Even 
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though the distribution of error for one fiducial in a particular set of measurements is usually Gaussian, 
the aggregated error for many fiducials can only be approximated to collide with it. 
Application accuracy refers to the overall targeting error of the integrated system while used in a clinical 
procedure or a mock setup. It realistically measures the task specific effectiveness of a system and is 
commonly used for validation. The application accuracy depends on all other sources of errors in a 
complex, non-linear way, therefore typically phantom, cadaver or clinical trials are required to determine 
it. Further problems arise with the simple, ergonomic expression of spatial errors. Physicians may need a 
single number showing the precision of the system. In many applications, only the absolute distance from 
a desired location matters, therefore the Root Mean Square Error (RMSE) is given for the system: 
RMSE ,
N
2
i
i=1
1
= (x - x)
N
   (1)
 
where N is the number of measurements, x is the desired point and xi is the i
th
 measured point. The RMSE 
is only an unbiased representation of isotropic and independent errors in the 3D space. For other cases, 
the covariance matrix of the error distribution should be used. 
Eq. (1) does not incorporate the angular errors of the system, even though any 3D registration or tracking 
component with a rotational error will affect the translational accuracy. Even worse, the factor of 
degradation is dependent on the value of the translational vector, due to the nature of the homogeneous 
transformation matrix multiplication. This is especially bothersome in the case of intra-operative 
navigation systems that are supposed to be used with a Dynamic Reference Base (DRB), therefore the 
rotational inaccuracy’s effect on the linear accuracy will depend on the distance between the camera and 
the patient, and will have anisotropic distribution. This model is valid for zero-mean Gaussian 
distributions, and RMSE gives a single value even to multi-dimensional distributions.  
In IGS, typically not only robots, but tracking devices are also incorporated, providing the necessary 
information for navigation. In the case of IG therapies, the same metrics could be applied; however the 
effect of imperfect registrations and coordinate transformations has major contribution to the overall 
error. Performance estimation focuses on precision, noise, static/dynamic accuracy or latency. Medical 
device manufacturers typically provide maximum spatial error values with standard deviations, and 
publish limited experimental results on the distribution of errors. According to (Frantz et al., 2004), two 
conditions are necessary to correctly assess a positioning system’s performance: 
• characteristic statistics (defining trueness and precision), 
• a specifically defined assessment protocol (on which the measurement is based). 
Evaluating robotic systems usually involves not only mathematical modeling and simulation, but also 
extensive accuracy tests. One of the difficulties in assessing an IG robot is to acquire the ground truth—
the gold standard. This is feasible through the use of a significantly more precise device (e.g., laser 
scanner, accurate camera system), the use of a measurement phantom or other trusted method (providing 
the ground truth). In industrial robotics, accuracy measures and tests have been widely used, and some got 
straight applied to CIS (Haidegger et al., 2010). Most commonly, the medical device is guided (directed) 
to different positions and orientations along a precisely known set of landmarks (fiducials) or an accuracy 
board. The positions can also be recorded with an independent localizer. 
 
STANDARDS AND METRICS TO FOLLOW  
To make any robot system available on the market, it has to comply with various regulations and 
standards. Safety is paramount for any surgical device, especially in the case of autonomous actuation. 
This issue has been addressed by many researchers, governmental bodies and scientific societies in the 
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past years, pushing for a unified standardization effort to ensure patient and medical staff safety in the 
operating room. System assessment is paramount for any prototype, and in interventional medicine, the 
device is most commonly in direct contact with the patient. This section collects the relevant regulations, 
focusing on the general approach, trends and requirements they implement. At this stage of development 
in advanced robotics worldwide, it is crucial that both the developers of new commercial systems and the 
authorities (working on new legislation for the field) understand the importance of accurate categorization 
and well defined methods to assess the capabilities and associated risk factors of the various systems 
(Virk et al., 2012).  
Current accuracy standards 
International bodies are exerting great effort to standardize medical robotics similarly to industrial 
robotics. However, there are no widely accepted regulations. Some of the existing robotic and medical 
device standards are applicable to CIS. (While these are changing periodically, the reader should be able 
to find the most up-to-date versions of the relevant regulations based on the ones listed here.) 
In 2004, the American Society for Testing and Materials (ASTM) initiated a new standards committee 
(ASTM F04.05) under the title Standard Practice for Measurement of Positional Accuracy of Computer 
Assisted Orthopaedic Surgical Systems (CAOS). The goal was to develop an international standard for 
metrology, validation and performance of CAOS systems (Stiehl et al., 2007). The first draft (dating from 
2007) deals with the localizer functions of navigation systems (optical, mechanical or electromagnetic). 
The defined generic measurement board—nicknamed Nebraska phantom—was machined from 
aluminum-alloy, and was tested with three different CIS systems (Barrera et al., 2007). It is a multi-
surface object with 47 identical fiducial points (0.75 mm deep cone-shape holes) distributed on its 
surfaces (Fig. 11a). 
 
 
Figure 11.  a) ASTM CAOS draft standard accuracy phantom (Stiehl et al., 2007).   
 b) NIST CAOHS Artifact for the verification of hip replacement surgery (Dagalakis et al., 2007). 
 
ASTM F04.05 developed a set of standard for specific tasks (cutting, drilling, milling, reaming), distinct 
surgical applications (joint replacement, implant nailing, plating, osteotomy) and imaging modalities 
(fluoroscopy, CT, MR, ultrasound). Supporting the ASTM group, a multi-institution technical committee 
presented a white paper, calling for standardization in many areas of CIS (Kazanzides, 2006), (Chiao, 
2008). Based on technological and economic analysis, metrology and standards should be applied 
especially to the following categories of medical devices: 
• computer-assisted navigation and surgery, 
• surgical robots (mostly in manual control mode), 
• surgical robots and phantom (artifact) devices, 
• stimulation devices, 
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• drug-delivery and physiologic monitoring devices. 
After a long time of preparation, it came to existence, the ASTM F2554 –10 Standard Practice for 
Measurement of Positional Accuracy of Computer Assisted Surgical Systems (2010). The final version 
addresses the techniques of measurement and reporting of basic static performance (accuracy, 
repeatability, and so forth) of surgical navigation and/or robotic positioning devices. It employs a highly 
accurate optical tracking system to perform system assessment.  
Another clinical phantom (the Computer-Assisted Orthopaedic Hip Surgery—CAOHS Artifact) was built 
at the National Institute of Standards and Technology (NIST) to quantify task specific measurement 
uncertainty. It was designed to mimic hip joint using magnetic ball-and-socket to be able to simulate hip 
replacement procedures (Fig. 11b).  
 
Accuracy measurement standards relevant to the field 
Several standards exist for medical devices in general (e.g., from the International Electrotechnical 
Commission – IEC), separately for industrial robotics and for safety-related systems; FDA has its Quality 
System Regulation (QSR) and the Process Validation Guidance (GHTF). However, none of these 
addresses surgical robotics directly. The ISO 10360 standard “Acceptance and reverification tests for 
coordinate measuring machines (CMM)” from 1994 (current version: 2011) can be applied to surgical 
robots in many cases (mostly to semi-autonomous systems). It defines the protocol for CMM based on 
Volumetric Length Measuring Error (VLME) and Volumetric Probing Error (VPE).  
Telesurgery requires additional regulations. A report from (Gartner 2008) discusses technical and human 
issues based on the existing standards according to 1993/42/EEC, Medical Devices Directive (MDD) and 
the third edition of the IEC 60601-1 (2006) for tele-neurology. According to it, manufacturers of 
telemedical systems for neurology are required to: 
• determine the medical purpose §3.10 of MDD, 
• carry out risk classification and risk management (according to DIN EN ISO 14971), 
• completely meet the requirements of MDD Annex I. 
Examples of accuracy measurements  
In indirect IGS, 3–5 mm RMSE application accuracy is considered acceptable, whereas 2 mm is 
recommended for IG neurosurgery. In the meantime, sub-millimeter precision is recommended for robot 
assisted procedures―direct IGS (Grunert et al., 2003). When CIS system accuracies are reported in 
research papers, many times, neither of the generic standards is followed. Instead, custom metrics, 
protocols and measurement boards are used. As a consequence, it is extremely hard to effectively evaluate 
and compare the results. Most often, the experiments are not described in details (e.g., application 
accuracy refers only to a single component of a system). While these protocols are better regulated in the 
industry, the assessment techniques are numerous both in the case of medical robots and surgical 
navigation systems. 
Table I summarizes the published accuracy measures for well-known surgical robots. These tests were 
mostly conducted in engineering laboratories, following different approaches. Understandably, the control 
mode of the robot can greatly influence the overall accuracy of the system. It should be noted that for 
master–slave systems (like the da Vinci), safety originates from keeping the human in the control loop at 
all times through real-time sensory feedback. This means the intrinsic positioning accuracy of the robot is 
not crucial anymore; the surgeon uses the provided visual information to compensate for any positioning 
errors. However, this approach introduces the generic limitations of a human operator (such as 
physiological latency), and even for these systems, the intrinsic accuracy of the components has 
significant effect on performance. 
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Table I   Different accuracies published for major surgical robot systems. Details of the 
experiments are not disclosed in many cases. (Values are given with mean ± standard deviation.)  
a
 
Target Registration Error  
b
 registration performed with a stereotactic frame (head fixator)  
c
 registration 
in frameless mode  
d
 Fiducial Localization Error. 
References: 
1 
(Kwoh et al., 1988); 
2 
(Paul et al., 1992); 
3 
(Taylor, 2001); 
4 
(Nishihara et al., 2006); 
5 
(Li et 
al., 2002); 
6 
(Varma et al., 2006); 
7 
(Haidegger et al., 2008); 
8 
(Kwartowitz et al., 2006); 
9 
(Kwartowitz et 
al., 2007); 
10 
(Dieterich et al., 2003); 
11 
(Jang et al., 2006); 
12,13 
(Cleary et al., 2006); 
14 
(Lieberman et al., 
2006). 
 
Safety standards and methods for CIS 
Safety is paramount for any surgical devices, and many kinds of errors may lead to critical conditions in 
the OR. According to (Satava, 2005), errors in interventional medicine can be categorized as:  
• commission: doing the wrong thing, 
• omission: not doing the right thing, 
• execution: doing the right thing incorrectly. 
For most of the CIS systems, failing at execution is typical, while diagnostic (decision support) systems 
can also generate other types of errors. Errors can be either systematic (a series of errors resulting in an 
adverse event) or specific (the event itself is a form of error). 
Failure mode analysis and risk assessment methods both for hardware and software in general have been 
addressed by many standards (Varley, 1999; Kazanzides et al., 2008; Kazanzides, 2009): 
• IEC 60812 International Standard on Fault Mode and Effects Analysis (1985), 
• IEC 1508 Functional Safety: Safety-Related Systems (1995), 
• ANSI/RIA R15.06-1999 for Industrial Robots and Robot Systems —Safety Requirements 
• European Norm (EN) 1441 on risk management (1997), 
• American National Standards Institute (ANSI) R15.06 standard for industrial robot safety (1999), 
• GHTF/SG3/N99-10:2004 Quality Management Systems—Process Validation Guidance (2004), 
• IEC 62304 on Medical Device Software—Software Life Cycle Processes (2006), 
• IEC 61025 Fault Tree Analysis (Ed. 2.0, 2006), 
• ISO 14971 Application of Risk Management to Medical Devices (2007), 
• ISO 10218-1 Robots and robotic devices - Safety requirements for industrial robots—Part 1: 
Robots, 
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• ISO 10218-2 Robots and robotic devices - Safety requirements for industrial robots—Part 2: 
Robot systems and integration, 
• IEC 60601 international standard on Medical Electrical Equipment (Ed. 3.0, 2010), 
• IEC 1508 draft standard on Functional Safety for software developers, 
• ISO 13482 Robots and robotic devices - Safety requirements for nonindustrial robots - Non-
medical personal care robot. 
Several groups have published methodologies to support the principles of safe design and development of 
robotic surgical devices. A generic one is the Hazard Identification and Safety Insurance Control (HISIC) 
policy, that has been applied to multiple surgical robotic systems so far (Fei, 2001). HISIC breaks down 
the issue into seven principles:  
• definitions and requirements, 
• hazard identification, 
• safety insurance control, 
• safety critical limits, 
• monitoring and control, 
• verification and validation, 
• system log and documentation. 
Further, a Computational Evolution method (Varley, 1999) and a Unified Modeling Language (UML) 
based approach have been successfully prototyped (Guiochet & Vilchis, 2002), relying on safe design, 
safe execution and risk assessment as cornerstones. Risk management in general is a key component of 
the entire medical device safety. This includes (Guiochet & Vilchis, 2002): 
• risk analysis (system definition, hazard identification and risk estimation), 
• risk evaluation (determine risk tolerance levels), 
• risk control (implementing the right action for maximum safety). 
 
CLEARANCE PROCEDURES 
Testing a prototype is only the first step towards commercialization, acquiring certification involves many 
other issues. To objectively evaluate the performance of a robot-assisted system, it is crucial to 
understand and apply consistent measurement methods. However, many other factors determine the 
success of a surgical robot beyond spatial precision. The accuracy of treatment delivery remains the 
baseline for applicability; a medical robotic system should still address the questions of complexity, cost 
and ergonomics. Different systems should be measured and assessed through the same validated 
experiments. 
The existing industrial standards and medical robotics related drafts should be extended to all major areas 
of CIS. Surgical robot systems typically have an application accuracy between 1–2 mm. This means 
lower precision that of industrial robots, mainly due to the accumulation of different errors in IGS, 
preventing sub-millimeter accuracy. (Although sometimes, sub-millimeter inherent robot accuracy is 
wrongly claimed as overall precision.) A robot must be intuitive and require minimal maintenance and 
engineering skills to operate (Kazanzides et al., 2008). The user acceptance of a system will eventually 
determine the value of the device, therefore one of the major directives of development is to minimize the 
change to the existing clinical workflow. These ideas are typically represented in the medical device 
regulations. 
International regulations for CIS 
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Clearance applications (and the following continuous communication with the regulatory bodies) include 
discussion of electronics design, imaging systems’ performance, embedded software analysis and clinical 
trial design and patient outcome validation. The procedures both in Europe and in the U.S. are focusing 
on the safety and transparency of systems (Taylor & Kazanzides, 2008). Most prototype development and 
testing begin with the official approval of the Institutional Review Board (IRB), legally taking 
responsibility for the primer operations. 
In the EU, the CE mark must be obtained, certifying that the product complies with the essential 
requirements of the relevant EU health, safety and environmental protection legislation. The approval 
procedure is managed by independent Notified Bodies (NB), accredited by Brussels centrally. There are 
over 75 international, non-governmental NB for medical devices. ISO 9000 Quality Standards family is 
applied to verify the production management of a company (www.iso.org/iso/iso catalogue.htm). ISO 
9001:2000 combines three previous standards (9001, 9002 and 9003), addressing design and development 
procedures under the title “Quality management systems—Requirements”. 
For CIS systems, the ISO 13485:2003 (Medical devices—Quality management systems—Requirements 
for regulatory purposes) is in effect. It is possible for ISO 9001 complied companies to self-certify (CE 
mark) their products within certain limitations, and the NB would periodically audit them.  
U.S. practices 
In the U.S. only the federal Food and Drug Administration can clear medical systems 
(www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/default.htm), since the 1976 Medical 
Device Amendments. The Safe Medical Device Act (1990) defined the present regulatory structure 
requiring that all medical devices should ensure safe and effective use (DiMaio et al., 2011). “An 
Investigational Device Exemption (IDE) allows the investigational device to be used in a clinical study in 
order to collect safety and effectiveness data required to support a submission to FDA. (FDA, 2011)” For 
initial trials, FDA requires an IRB approval certifying that the device in question poses only insignificant 
risk. If an investigational use of a new system (or with a new procedure) poses significant risk to the 
patient, the IDE needs an FDA approval. Next, to allow further clinical investigation of a new device, the 
IRB and the FDA must determine the followings (Bronzino, 1990): 
1. risks to subjects are minimized, 
2. risks to subjects are reasonable in relation to the anticipated benefit and knowledge to be gained, 
3. subject selection is equitable, 
4. informed consent materials and procedures are adequate, 
provisions for monitoring the study and protecting patient information are acceptable. 
The FDA review team incorporates experts from various fields, and if needed, they may hold a Public 
Advisory Panel meeting, to obtain a second opinion from external professionals.  
Before the whole clearance procedure is initiated, it is a good idea to ask for a pre-submission meeting 
from FDA, where it is possible to get informal feedback from an FDA review team on the preliminary 
data and concept. Clearance can be done primarily in the form of a Pre-Market Approval (PMA) 
procedure—which is for new devices—requiring extensive clinical trials and huge amount of 
documentation. Table II summarizes these requirements for different kinds of systems. A PMA 
submission can costs approximately $240K, although a reduced pricing is applied for small businesses, 
and it has 180-day review cycle.  
On the other hand, the Premarket Notification pathway, the 510(k) is for equipment that can be proved to 
be “substantially equivalent” to an existing device, already approved by FDA. Substantial equivalence is 
meant in terms of safety and effectiveness with respect to intended use and design, compared to a 
predicate device. It has a 90-day-long review cycle, and may still require clinical trials, but less extensive 
than for PMA. All systems must comply with FDA Quality System Regulations/Medical Device Good 
Manufacturing Practices (Code of Federal Regulations Title 21, Part 820) (Lowery et al., 1996).  
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While there are 3–4000 independent 510(k) submissions annually, only 30–50 PMAs arrive to FDA. The 
basic idea behind these regulations is to prevent failures and issues originating from bad design. The 
clinical use and patient outcome might not even be verified during the validation. At the most, the system 
should show the capability to perform a procedure with the same effectiveness as an existing (manual) 
technique. FDA is used to rely on the selectivity of the market, which should only allow for the existence 
of well-sustained systems with significant added value to the surgical procedure. 
Systems are classified into three main categories, depending on the risk they pose to the patient, the user 
and the based on the intended way of use:  
• Class I: low risk devices (45% of the submissions, many exempt), 
• Class II: medium risk devices (45%, usually 510(k)), 
• Class III: devices involving high risk to the patient, e.g., life-sustaining equipment (<10%, 
typically PMA).  
 
 
Table II  Summary of classification of CIS devices and their testing requirements in the U.S. 
(Janda & Buch, 2009). 
  
The da Vinci robot was originally categorized as Class III, and initiated its clearance procedure via PMA. 
Later, it was advised to convert to 510(k), and eventually got approved as a Class II device. When 
performing objective system assessment, FDA looks into the following issues in the case of CIS systems 
(Janda & Buch, 2009): 
• How accurately do the system’s actions reflect the operator’s intent? 
• Does the device enhance surgical capabilities? 
• How does the computer “intermediary” affect operative flow? 
• How easily are glitches in the technology handled? 
• Are there procedures and/or anatomic sites that are more or less amenable to this technology? 
• How steep is the learning curve? 
• What criteria are used to “optimize” a preoperative plan? 
• How and when should the user override the recommendations of the system? 
• How does the system define anatomic references and axes? 
• How does the system dictate the surgical workflow, and how does this differ from traditional 
techniques?  
 
General requirements for medcial software 
Since robots also consist of software parts, it is important to know that for all software and apps that meet 
the definition of a medical device, the EN62304:2006 regulatory guidance is applicable 
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(http://www.mhra.gov.uk/Howweregulate/Devices/Software/index.htm). Software, which drives a device 
or influences the use of a device automatically falls into the classification of that. Regarding robotic 
devices, there are a few more thumb rules: 
 Active therapeutical devices are generally Class IIa, yet potentially hazardous ones are Class IIb. 
 Active devices intended for diagnosis are generally Class IIa – or Class IIb, if hazardous  
 Other, non-hazardous Active Devices fall under class I. 
While compliance to Class I devices is based on self-declaration by the manufacturer, all other devices 
require use of a notified body to assess compliance. Clinical data is required for all medical devices and 
for some novel software clinical investigations may be needed. Manufacturers have a responsibility to 
implement an effective post-market surveillance system to ensure that any problems or risks associated 
with the use of their device once freely marketed are identified early, reported to competent authorities, 
and acted upon. This is known as the medical devices vigilance system. For software, a system of 
registration/activation may aid the manufacturer trace devices that have been distributed by third party 
distributors or by app stores. This is important when undertaking any corrective action such as a recall. 
 
The ROBODOC case 
The clearance procedure of the ROBODOC system stretched long and full of edifying stories. It was the 
first robotic system that tried to get through the FDA clearance procedure, and it was forced into the PMA 
category, since no equivalent technology existed (Curexo, 2009). 
• October 1992, the FDA granted an IDE approval to conduct limited clinical trials (at Sutter 
General Hospital in Sacramento). 
• November 7, 1992, the world’s first robotic joint replacement surgery was performed. 
• A biomedical engineer for the FDA outlined comprehensive investigative testing designed to test 
the safety of the robotic control software.  
• 1993, ISS began the PMA clearance procedure. The ROBODOC software and hardware had to 
comply with robust motion control restrictions to prevent accidental tissue and bone damage.  
• 1996, it received the European CE mark and approval for THA procedures.  
• 2002, the FDA re-assigned the ROBODOC system to the 510(k) path. Unfortunately, by this 
time, ISS no longer had sufficient capital to support the procedure. 
• By 2004, the significant R&D cost related to further testing and re-submission caused ISS to 
cease operations.  
• November 2007, all assets and IP were transferred Curexo Technology Corporation, and $12M 
was invested to continue operations. 
• The fresh money allowed to finish trials, and to complete the robot’s commercialization via FDA 
510(k). 
• In August 2008, the system finally received a 510(k) clearance from FDA, yet the change of 
times forced the company to return to the design boards to develop a new version of the system.  
 
Throughout these years, all the FDA-cleared surgical robots (e.g., da Vinci, NeuroMate, CyberKnife, 
ROBODOC, MAKO Arm, SpineAssist) went down the 510(k) procedure, proven to be substantially 
equivalent to existing (manual) technologies. FDA’s emphasis has gradually shifted from the robotic 
technology itself to approving the results of the use of the robotic systems. It is now believed that the 
equivalence stands between the already-approved surgical techniques and the results attained through 
robotic interventions.  
Current trends 
Regulatory bodies have realized the need for a better approach to the dynamically growing field of CIS. 
Since 2010, the 2007/47/EC (European Council) regulation extended the existing 1993/42/EEC MDD, 
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requiring specific clinical data for new devices and companies are expected to do to ensure safety and 
demonstrate the performance of their product, regardless of the classification of the device. The directive 
also requires risk and benefit analysis, and the sustained and coordinated clinical post market surveillance 
of the products. It came into effect in 2012 in Europe and in Canada, and from June 2013 in the U.S. In 
addition, software developed for diagnostic or therapeutic purposes has become classified as a medical 
device in the EU. 
A workgroup was created in 2009 to prepare an extension to the existing ANSI/AAMI ES60601-1:2012 
standard on Medical Electrical Equipment, focusing on medical robotics and personal care robots. 
Working together with the subcommittee of the ISO TC 184, dealing with robotic devices, the priorities 
of the new standard are: 
• defining medical software systems and associated technical requirements, 
• streamlining the application of risk management, 
• clarifying the definition of essential performance, 
• identifying essential performance and mitigating risk. 
The ISO/TC 184/SC 2 technical sub-committee on Robots and Robotic Devices proposed the formation of 
a joint work group with the IEC/SC 62A subcommittee (Common Aspects of Electrical Equipment used 
in Medical Practice) under IEC administration to develop a new proposal for a Collateral Standard within 
the IEC 60601 family. The scope of the standard would be to the basic safety and essential performance 
requirements for medical electrical equipment and in addition, systems employing robotic technology 
(i.e., medical robots). 
In the EU, updates to the IEC 60601-1 means that regulatory bodies decided to require supportive medical 
data as evidence for the safety and performance of new systems. Beginning in June 2012, risk assessment 
and analysis for every medical device designer and Original Equipment Manufacturer (OEM) will be 
mandatory.   
The FDA’s 510(k) procedure is going under major revision based on the complaints filed by the device 
manufacturers. Two committees were created: 510(k) Working Group and the Task Force on the 
Utilization of Science in Regulatory Decision Making (CDRH, 2010). Improvements should include the 
clarification on clinical data requirements and the implementation of more transparent, science-based 
decision making structure, specifically: 
• When and what type of manufacturing data to submit? 
• When a pre‐clearance inspection would be conducted? 
• When and what types of modifications should be periodically reported in lieu of submitting a 
510(k)? 
• When and what type of safety and effectiveness information for the device to be reviewed that is 
known to the manufacturer should be submitted as a brief description? 
 The aim is to reduce the number of failures through more thorough tests before the release, especially for 
devices such as defibrillators, hip implants and hospital pumps (FDA, 2010). 
The Institute of Medicine (IOM) concluded that it would be better to develop an integrated pre-market and 
post-market regulatory framework that provides a reasonable assurance of safety and effectiveness throughout 
the device life cycle (IOM, 2011). “The new framework should be:  
• based on sound science, 
• clear, predictable, straightforward and fair, 
• risk-based,  
• be self-sustaining and self-improving, 
• facilitate innovation that improves public health by making medical devices available in a timely 
manner and ensuring their safety and effectiveness throughout their lifecycle, 
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• use relevant and appropriate regulatory authorities and standards throughout the life cycle of 
devices to ensure safety and effectiveness.” 
 
FUTURE RESEARCH DIRECTIONS 
In the past 10 years, we have seen the dynamic growth of the field of CIS, and the best surgical robots 
gradually reached clinical application. Da Vinci is dominating the market, however, several competitors 
are on the way, relying on the reputation surgical robots have already achieved. The success of Intuitive’s 
system inspired many groups: 
The development of the Telelap ALF-X system (Advanced Laparoscopy through Force- RefleCT(X)ion) 
began around 2008 at SOFAR S.p.A., (a pharmaceutical company in Milan), with retrofitting industrial 
manipulators to create a da Vinci competitor (Fig. 12a). They are supported by an EU joint effort, and 
operating under the academic assistance of the New European Surgical Academy (NESA). Next, they 
teamed up with Immersion Corp. to ensure a good haptic interface (TouchSense) for their robot, and 
submitted numerous patents. Features of the robot include force control, preoperative simulation, intra-
operative virtual reality overlay, automated fulcrum point identification and real-time patient monitoring. 
Their system is capable of 1.5 mm application accuracy and under 60 ms latency in the control. The 
system’s main application would by gynecology. Preclinical trials with the robot have been performed, 
focusing on hysterectomy, salpingo oophorectomy, myomectomy, partial and radical nephrectomy, total 
pelvic exenteration and cholecystectomy (Tinelli et al., 2011). 
 
Figure 12.  b) CE marked version of the ALF-X system (Tinelli et al., 2011).  d) The Raven II from 
the BioRobotics lab at University of Washington. (Courtesy of UW.)  c) Sofie, developed at 
Eindhoven University of Technology. (Courtesy of EUT.) d–e) The Canadian SPORT system. (Courtesy of 
Titan Medical Inc.) 
The KUKA Lightweight arms (LW) and iwa are the commercialized version of the DLR III arm (7 DOF, 
fully sensorized, compliant) is preferred solution for many procedures (e.g., for the Active FP7 project), 
and now KUKA LBR Med is sold by the company directly for medical applications as well 
(http://www.kuka-labs.com/en/medical_robotics/). It is also an important feature that the KUKA robot 
does not use cable-drive, therefore does not collide with Intuitive's patents on the technology.  
The BioRobotics Lab at University of Washington has developed a portable surgical robot that can be a 
compromised solution to install on space crafts with its 22 kg overall mass (Fig. 12b). The robot—called 
Raven—has two articulated arms, each holding a stainless steel shaft for different surgical tools. It can 
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easily be assembled even by non-engineers, and its communication links have been designed for long 
distance remote-control. Besides the possibility of haptic feedback, additional sensors are mounted on the 
robot to provide more information to the surgeon and to avoid any critical failures due to communication 
delay. Throughout the entire development, compactness was handled as priority, the creators optimized 
the robot’s dimensions and range-of-motion by computer, minimizing the space it occupies without 
compromising on manipulation capabilities (Lum, 2008). The new generation robot, Raven II was 
distributed to seven university clinics and research labs in North America and Western Europe, and is 
now commercialized as an open research platform by Applied Dexterity Co. 
(http://applieddexterity.com/).  
The Surgeon’s Operating Force-feedback Interface Eindhoven (Sofie) is a surgical robot developed at the 
Eindhoven University of Technology (van den Bedem, 2010). It is a compact surgical robot, integrating 
force feedback to allow the surgeon to feel what he or she is doing (Fig. 12c). Tactile feedback is 
provided in the master side joysticks. This counter pressure enables a surgeon to feel exactly what force 
he applies when making a suture or pushing aside a bit of tissue. Sofie is smaller, bed-mounted, hence it 
is less of an obstacle in the operating theater and above the patient. This avoids the otherwise necessary 
re-arrangement when the operating table and the patient are moved or tilted. Further, Sofie makes it 
possible to approach an organ from different sides thanks to its flexible tools. 
In 2009, a Canadian company—Titan Medical Inc. (Toronto, Ontario Canada)—announced its new four-
armed manipulator system, the Amadeus, now called the SPORT (Rayman, 2009). The robot is being built 
in cooperation with Bell Canada’s Health Division to integrate Internet Protocol based advanced 
telesurgery capabilities for Amadeus. Titan Inc. announced in 2011 that they would use KUKA arms for 
the setup, yet they switched to a single-port solution licensed from Columbia University, and renamed the 
system to Single Port Orifice Robotic Technology—SPORT (Fig. 12d–e). Strategic agreements have been 
made with Canadian hospitals for the trial of the system, and currently a first clinical prototype is 
undergoing animal trials. The commercial product is expected in 2016.  
An Italian spinoff company of the University of Verona—Surgica Robotica Ltd.—has been developing 
Surgenius since 2009. This robot is based on NASA’s RAMS system that was developed in the mid-
1990s. It was recognized by the euRobotics Technology Transfer Award. After is passed pre-clinical (in-
vivo, in-vitro) trials for system validation, it got CE mark in 2012. Currently, it is waiting for further 
funding to reach commercial status.  
Future evolution of the field 
Current research projects are trying to increase the utility of the surgical equipment along different 
strategies. They are mainly focusing on three areas for improvement: 
• augmenting the overall accuracy and/or efficacy of the classic stereotactic systems, 
• increasing the added-value of the equipment, 
• further enhancing the capabilities of the human surgeon, providing smarter tools. 
 
The following ongoing research examples give insight to how these issues are addressed and what are the 
benefits for future patients. Safety is paramount in all cases, and should determine the way research is 
conducted. Patient safety is addressed differently in each discussed system. 
 
Improvement of stereotactic surgery 
A good example of this concept was the European Union’s FP7 project—ROBOCAST (Robot and 
Sensors Integration for Computer Assisted Surgery and Therapy)—aimed to augment existing IGS 
techniques and to find new ways to perform high-precision keyhole neurosurgery (Comparetti et al., 
2011). The modular system consisted of two manipulators and one smaller probe, actively cooperating in 
a bio-mimetic sensory-motor integrated framework (Fig. 13a). Mazor’s (Caesarea, Israel) SpineAssist was 
used as a robotic end effector by itself, enhanced with a linear drive for needle insertion (Lieberman et al., 
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2006). The 6DOF PathFinder system (Prosurgics Inc., UK) forms the larger positioning robots. (The 
stereotactic PathFinder used to be available on the European market for other IG procedures.) It works 
with the CT or MRI images of the patient and automatically registers the position of the probe (with at 
least 1.25 mm accuracy).  In general practice, it is capable of aligning the surgical tools within 1 mm of 
the target. The ROBOCAST system used optical trackers for patient safety (to monitor and compensate 
for any change in the patient’s position) and provided visual information of the surgical field. Given an 
accurate registration, the controller could use the preoperative diagnostic information to plan the path of 
the intervention.  
 
  
 
Figure 13. a) The final demonstration of the ROBOCAST system (Comparetti et al., 2011).  b) The 
first clinical prototype of the MRI-compatible neuroArm. (Courtesy of University of Calgary.)
 c) Concept design for the commercial version of neuroArm—SYMBIS. (Courtesy of IMRIS.)  
 d) The Steady-Hand/Eye Robot at JHU. (Courtesy of the Johns Hopkins University.)   
e–g)  Experimental setups of the ACTIVE system (ACTIVE, 2014).  
 
 
Integrating imaging devices 
The other main direction of development is to integrate the robots with advanced imaging devices to 
increase their utility by allowing intraoperative imaging (Tsekos et al., 2007). This can be very 
challenging technically, as the robot has to be constructed of non-magnetic and dielectric materials such 
as plastics, ceramics and rubber. MR compatibility is considered to be one of the greatest advantages a 
robot may have, allowing continuous image-guidance through intra-operative imaging, and avoiding the 
need of image registration (Gassert et al. 2008). MRI gives a fine resolution picture of soft tissues within 
an acceptable timeframe, while avoiding patient and surgeon radiation exposure. MR compatible robotics 
has been in the focus of research interest since the mid ‘90s, and numerous systems have been developed.   
NeuroArm (Sutherland et al., 2013) is a teleoperated anthropomorphic robot from a University of Calgary 
led consortium (Fig. 13b). The MR safe robot (compatible up to 1.5 Tesla magnetic field) is designed for 
stereotaxis and microsurgery. Beyond motion scaling and high definition visual feedback, the neuroArm 
is able to provide very accurate 3D information of its two 7 DOF arms. It uses three displays to give 
complete visual coverage of the operating environment, showing in parallel the 3D stereoscopic view of 
the operation, the MR image of the patient and the control panel. The system has been used on a few 
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human patients so far, and after further clinical trials, it may hit the market within a few years in a new 
format, designed and engineered by the Canadian IMRIS (Fig. 13c). A major barrier however is the 
increased cost of the MR compatible components. 
At Johns Hopkins University, researchers have already developed several generations of MR compatible 
robots, mostly for prostate brachytherapy (Krieger et al., 2011). They are considered to be the leading 
center in brachytherapy system development, together with Queens University in Kingston, ON 
(Fichtinger et al., 2012).  
Other groups, such as the Automation and Interventional Medicine Laboratory at WPI target similar 
procedures, such as Deep Brain Stimulation (DBS) with significantly smaller scale robots that can fit into 
the gantry of conventional, diagnostic MRI (Cole et al., 2009, 2014). Closed, high-field scanners are used 
for guiding DBS electrode placement interventions relying real-time guidance. It may be used for 
treatment of Parkinson's disease and other disorders including severe depression and Alzheimer's disease. 
Hands-on surgery with advanced features 
Another neurosurgical research project at the JHU is a good example of the cooperative control concept 
(Fleming et al. 2008). The hands-on system—called formerly the Steady-Hand, and now the Eye Robot—
is capable of significantly increasing the performance of human surgeons (Fig. 13d). The robot holds 
interchangeable tools and the force sensor that has low-threshold silicon strain gauges built in to detect 
forces. The force measurements are coupled to the control system after tremor filtering and smoothing. 
This approach has the advantage of simplicity, less expensive implementation and provides greater 
immediacy for the user. However, the possibility of teleoperation is completely lost. Surgeons may be 
more willing to accept this form of robotized equipment, as it still supports the classical way of doing the 
procedure. The robot is based on a Cartesian stage (allowing three orthogonal translational motions) and a 
RCM stage (with two orthogonal rotational DOF) that helps to keep a user-defined point (RCM) of the 
robot at the same position in space. This allows safe surgery through the abdomen (or other tissue layers), 
where the incision point limits the motion in space 
(https://ciis.lcsr.jhu.edu/dokuwiki/doku.php?id=research.eyerobots).   
Another EU FP7 consortium has been formulated for the development of advanced robotic systems, 
under the name ACTIVE: Active Constraints Technologies for Ill-defined or Volatile Environments. A 
lightweight and agile 20 DOF redundant robotic cell is to be created (Fig. 13e–g). An advanced 
processing unit for pre- and intra-operative control operates both autonomously and cooperatively with 
humans. Two cooperating KUKA LW robots interact with the brain that prone to deform for the tool, 
blood pressure, breathing and deliquoration. Automated compensation techniques are developed for 
patient motion. The setup is primarily aimed to help with neurosurgery procedures, such as awake DBS 
for the treatment of epilepsy (ACTIVE, 2014).  
 
There are other concepts and approaches that seek to find ways to better serve the clinicians. Any new 
strategy must be developed using the same strategic principles:  
 the system should pose minimal risk to the patient (compared with classical methods),  
 there shall be major clinical advantages to justify its use and finally,  
 the investment and maintenance costs should be reasonable for medical centers.   
 
Minimally invasive surgical techniques 
Minimally invasiveness has been in the focus of clinical practice and the development of new systems, to 
the extreme of making no visible scars on the patient. Natural Orifice Transluminal Endoscopic Surgery 
(NOTES) was born 5 years ago to support surgical technique performed with a flexible endoscope and 
tools passed through a natural orifice (mouth, urethra, anus, etc.) then through an internal incision in the 
stomach, vagina, bladder or colon, thus avoiding any external incisions or scars. The name was invented 
at the Johns Hopkins Medical Institution, when first used on animals by Dr. Kalloo, as a developed 
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version of single port laparoscopy (also called Single Incision Laparoscopic Surgery—SILS). The first 
human operation was in June 2007, a transgastric cholecystectomy (Dallemagne et al., 2009.) 
NOTES provides numerous patient benefits, such as reduced pain, faster recovery, better cosmetic 
outcome (making it popular e.g., among models) and lower risk of infection. One of the great advantages 
is that theoretically no sterile environment is required, only sterile equipment. On the other hand, it is 
easier to cross-contaminate different compartment within the body. The single port entry means serious 
limitations in spatial motion, but also making laparoscopy manageable in obese patients, children or burnt 
patients. Hyper-redundant endoscopes must be used to achieve in-body navigation, and many surgeons 
are needed to manipulate these devices. Research labs all around the world are trying to provide an 
automated tool for NOTES. One example is the MASTER (Master And Slave Transluminal Endoscopic 
Robot) from the Nanyang Technological Institute, Singapore, which uses a bigger, 16 mm endoscopic 
tube to introduce a two-armed manipulator to the surgical field. Some limited clinical trial (endoscopic 
submucosal dissection) of the system has been conducted (Kok, 2011) 
(http://clinicaltrials.gov/show/NCT01394861). 
There are many other ways to advanced MIS this technology, such as combining it with real-time 3D 
visualization and augmented reality applications, such as the MUSTOF endoscope (Multi-Sensor-Time-
Of-Flight) from Friedrich-Alexander University, Germany (Höller, 2010). 
As of today, NOTES is still looking for a good clinical application that would best benefit from the 
development and justify the higher patient risk, costs and limited ergonomics of the procedures. The main 
goals of the Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR, 
www.noscar.org) working group are to solve the question of stability and navigation in the next five 
years while providing more advanced tools with the capability of triangulation, and additional features 
such as stapling and closing. 
Catheter robots 
Catheter-based procedures are wide-spread and representing an emerging field, therefore various robotic 
systems are aiming to improve these procedures (Antoniou et al., 2011). Hansen Medical’s Magellan 
peripheral intravascular interventions robotic heart ablation system (FDA approved in 2011), and they 
also have the Sensei X robotic system for heart ablation on the market. Navigation of catheters is a key 
issue, and also in the focus of numerous research projects, such as the EU FP7 Smart CATheterization 
(SCATh) project, led by the Katholieke Universiteit Leuven. It is focusing on the improvement of visual 
and haptic tools for robust and accurate catheter guidance by fusing preoperative patient-specific 
anatomical and mechanical models and intra-operative data streams from in situ sensors. A remote-
controlled catheter guiding robot was used in Milan in 2006 to automatically perform cardiac ablation, 
initiated and supervised by a group of professionals from Boston, MA. The robot used high magnetic 
fields to insert the catheter to the desired location, taking advantage of the pre-operative CT scans of the 
patient and real-time electromagnetic navigation. Initial trials were performed on 40 patients before the 
telesurgical experiment took place. The novelty of the system was that it could create the surgical plan on 
its own, relying on an anatomical atlas built on 10,000 patients’ data (Pappone et al., 2006). 
One of the recent competitors, FLEX emerged in for ENT applications. Howie Choset invented a cool 
snake-like robot for climbing poles at CMU, and with NIH funding created the first generation prototype 
with 11 millimeters in diameter. It was called CardioARM, featuring 102 joints. In 2009, they founded 
Cardiorobotics, and started limited trials the next year in the Czech Republic. However, soon they 
realized that cardiac procedures are just too complex and patient-specific to robotize efficiently. Thus 
Medrobotics Inc. was born, with a focus on head-and-neck surgery. By the end of 2011, the company has 
raised $28.3M in three rounds, from business angels, and since then, they raised another $43.6M, and 
eventually about to gain FDA approval in 2014 (http://surgrob.blogspot.hu/2014/06/updates-on-flex-
system.html). The Flex is capable of  integrating third party manufactured instruments fitting into the tool 
channel, and equipped with (only) 2D HD camera with adjustable depth-focus. 
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Microrobots 
Another direction of development is toward small scale, in-body (typically capsule) robots (Toennies et 
al., 2010) and (Nelson et al., 2010). These offer great advantages, as they are always remote controlled, 
facilitating the spatial displacement of the physician from the patient. Instead of the massive rigid 
structure applied for human-scale robots, these are often modular and reconfigurable. Micro-
EectroMechanical Systems (MEMS) allow for the design of structures or devices in the micro or even in 
the nano scale (Rebello, 2004). MEMS devices could either be (Cretu, 2010): 
 diagnostic microsystems: for rapid point-of-care, systems on a chip, cell and molecule sorting, 
DNA diagnostics, 
 surgical microsystems: for MIS, CAD-assisted surgery, microrobotics, 
 therapeutic microsystems and prostheses: drug and gene delivery, tissue augmentation/repair, 
biocapsules, micro/minimally invasive surgical systems. 
Researchers at the University of Nebraska developed a special mobile in-vivo wheeled robot for biopsy 
(Rentschler et al., 2006). Equipped with a camera, the coin-sized robot can enter the abdominal cavity 
through one small incision and move around the organs teleoperated. The robot is able to traverse the 
abdomen without causing any tissue damage, therefore reducing patient trauma. More recently, the group 
has developed various swallowable robots, controlled with external magnets (Lehman et al., 2009). 
The CRIM group at the Scuola Superiore Sant’Anna (Pisa, Italy) leads an FP7 funded international 
research collaboration to develop tethered, partially autonomous robots to perform surgery in the 
endolumen: Array of Robots Augmenting the KiNematics of Endoluminal Surgery (ARAKNES) project 
(Menciassi & Dario, 2009) and (Harada et al., 2009). The project was originally aiming at tethered 
NOTES robot, but more recently, the groups has changes to SILS approach. Another EU FP7 project—
Vector—targets the creation of effective capsule robots for local surgical procedures all along the gastro-
intestinal tract (Eiriki et al., 2009). 
Nanorobots 
Nano-scale devices may be used for transporting, delivering and targeting drugs. This means the 
assembling and control of individual modules such as nano-actuators and nano-sensors through molecular 
Computer-Aided Design (CAD). System concepts exist to affect various biological procedures, e.g.,  
repairing damaged cells or the DNA. Artificial red blood-cells could absorb a hundred times more 
oxygen, and nano-robot swarms could be directed around the body with external magnetic fields (Martel 
et al., 2008).  
One of the most prominent groups in this area is at the Swiss Federal Institute of Technology Zurich 
(ETH). They are also involved in the NANOMA project, aiming at the development of a drug delivery 
microrobotic systems. It uses ferromagnetic microcapsules in the cardiovascular system, navigated via the 
induction of force from magnetic gradients generated by an MRI machine (Vartholomeos et al., 2011). 
The projects results were transformed into a spin-off company, AEON Scientific that developed a market-
ready product (http://www.aeon-scientific.com/) 
Magnetic manipulation 
Magnets are used in various ways to actuate small-size surgical robots (Menciassi, 2011). Groups around 
the world are focusing on permanent or uniform fields for manipulation, especially in tubular structures. 
The use of non-uniform fields enable the generation of more powerful magnetic fields, which is desirable 
for in vivo applications, and it can be used e.g., steering cochlear implants, reducing the trauma of the 
surgery (Kummer et al., 2010). A different approach is applied in the Italian national Microsystems for 
Vascular diagnosticS and intervention (Micro-VAST) project, to have a permanent magnet mounted on 
an external robotic arm to control a micro-robot (Ciuti et al., 2010) . Other systems use magnets for 
anchoring, e.g., modular NOTES robots (Lehman et al., 2009). 
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Many of these initiatives are covered by Europe-wide EU FP7 coordination actions, such as EuroSurge 
(http://eurosurge.eu). This project aimed to aimed to create a conceptual integration platform for 
Computer and Robot Aided Surgery (CRAS) research and manufacturing, founding the bases of advanced 
applied research.  
 
CONCLUSION 
Advanced mechatronic systems became widely used to support complex applications, even in the realm 
of medical procedures. This chapter dealt with specific issues regarding the prototyping of Computer-
Integrated Surgical systems and surgical robots. CIS systems are primarily developed to provide patient 
benefits through increased precision and minimal invasiveness. Furthermore, robotic devices may allow 
for refined surgical treatment unimaginable without technological support. Various system development 
approached have been introduced through real-life examples, also pinpointing the difficulties, such as 
connecting interdisciplinary technologies, validation for regulatory approvals, or entering the market, and 
surviving against competing treatment forms. Creating an engineering prototype is only the first necessary 
step toward the development of a deployable new system. Slow establishment of standards specific to this 
area makes it harder to comply with applicable patient safety and process verification regulations and 
guidelines. The chapter gave an overview of these standards in order to facilitate future surgical robot 
developers. Systems currently under development will offer deliver great clinical advantages and 
improved safety features providing benefits both to the patient and the surgeon. It is believed that 
gradually research projects will find easier ways to advance from early phase towards more mature 
prototypes. Eventually, more revolutionary devices should emerge, ready for clinical trials, validation and 
hopefully, clearance at the end.   
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ADDITIONAL READING MATERIALS 
Surgical robotics and CIS have accumulated vast literature in the past 30 years. The most prominent 
articles are published in the Institute of Electrical and Electronics Engineers (IEEE) Transactions on 
Biomedical Engineering, Transactions on Robotics (former Transactions on Robotics and Automation), 
IEEE/ASME Trans. on Mechatronics, IEEE Robotics and Automation Magazine and in the various 
thematic journals, such as the Journal of Computer Aided Surgery (Taylor and Francis), Interntaional 
Journal of Medical Robotics and Computer Assisted Surgery (Wiley), Interntaional Journal of Computer 
Assisted Radiology and Surgery (Springer), Journal of Robotic Surgery (Springer), Surgical Endoscopy 
(Springer) and the Journal of Medical Devices (ASME). These publications are all available online. 
Accordingly, the number of surgical robotics related publications has been steadily rising (O’Toole et al., 
2010). Many books, tutorials and articles have been published on surgical robotics in the past 25 years, a 
subjective selection of the most notable ones include (Taylor et al., 2008), (Dario et al., 2003), (Taylor & 
Stoianovici, 2003), (Baik, 2010), (Ballantyne et al., 2004), (Pott et al., 2005), (Bozovic, 2007), (Faust, 
2007) and (Kazanzides et al., 2008) . The more generic field of surgical robotics is well covered by 
conferences, journals and periodicals. 
An earlier edition of this chapter appeared in IGI Book (T. Sobh & X. Xiong (Eds.) Prototyping of 
Robotic Systems: Applications of Design and Implementation , Bridgeport, CT. 
The Minimally Invasive Robotic Association (MIRA), the Society for Medical Innovation and Technology 
(SMIT), the Intl. Society and Conf. Series on Medical Image Computing and Computer-Assisted 
Intervention (MICCAI) and the Computer Assisted Orthopaedic Surgery (CAOS) organize topical 
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conferences every year. The Society of Photographic Instrumentation Engineers (SPIE) has numerous 
events, out of which the SPIE Medical Imaging conference is most attended by CIS professionals and 
industrial collaborators. In addition, the Medicine Meets Virtual Reality (MMVR) conference series, the 
Congress of Computer Assisted Radiology and Surgery (CARS), the Annual Intl. Conf. of the IEEE 
Engineering in Medicine and Biology Society (EMBC), the IEEE Intl. Conf. on Robotics and Automation 
(ICRA), the IEEE/RSJ Intl. Conf. on Intelligent Robots and Systems (IROS), the Conf. on Information 
Processing in Computer-Assisted Interventions (IPCAI), Joint Workshop on New Technologies for 
Computer/Robot Assisted Surgery (CRAS) and the biannual IEEE/ RAS–EMBS Intl. Conf. on Biomedical 
Robotics and Biomechatronics (BioRob) all welcome original publications on surgical robot prototype 
development. In addition, several portals and websites are dedicated to information sharing and 
knowledge distribution, providing free tutorials, video materials and presentations to assist robot 
development in every stage.  
It is worth mentioning some open source initiatives supporting the global research of CIS. The most 
widely used imaging platform is Sliced 3D (http://slicer.org/), offering full compatibility to common 
tools, such as VTK/ITK (https://boreas.med.yale.edu/base), IGSTK 
(http://public.kitware.com/IGSTKWIKI/) or MITK (http://www.mitk.org/MITK). CISST, a versatile tool 
for surgical robotics was developed at the Johns Hopkins University (https://www.cisst.org/cisst), and 
another one, PLUS at Queens University (https://www.assembla.com/spaces/plus/wiki ). There is NA-
MIC specifically for open source electromagnetic tracking (http://www.na-mic.org/Wiki/index.php/Open 
Source Electromagnetic Trackers). 
Probably the most complete source of clinical information are WebSurg (www.websurg.com) virtual 
university run by the European Institute of TeleSurgery (EITS, Strasbourg, France), the da Vinci Surgery 
site (www.davincisurgery.com) and the OR Live (www.orlive.com). An aggregating site is the All About 
Robotic Surgery (www.allaboutroboticsurgery.com), the MedGadget internet journal 
(www.medgadget.com), the ScienceRoll (scienceroll.com) and some relevant blogs (e.g., 
surgrob.blogspot.com, managed by the author). For specific devices and systems, information brochures 
and teaching materials are available at the manufacturers’ websites. 
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